Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
BEARISH SIGNAL DETECTED · Alpha
██.█% Sign up free to reveal

Dr Reddys Laboratories Ltd (RDY) AI Forecast

Our AI ranks Dr Reddys Laboratories Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

✓ Free account • ✓ 30-day free trial

$RDY Bearish Signal Full forecast available

Dr Reddys Laboratories Ltd (RDY) Stock Forecast Sept. 24, 2026


Dr Reddys Laboratories Ltd (RDY) AI Stock Price Forecast & Investment Analysis

Dr Reddys Laboratories Ltd Stock Price Chart and Technical Analysis

Loading chart...

Dr Reddys Laboratories Ltd (RDY) - Comprehensive Stock Analysis & Investment Research

Deep dive into Dr Reddys Laboratories Ltd's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on September 24, 2026 (UTC)

Dr Reddys Laboratories Ltd Investment Summary

When evaluating whether Dr Reddys Laboratories Ltd (RDY) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Dr Reddys Laboratories Ltd (RDY) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $10 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Dr Reddys Laboratories Ltd's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Dr Reddys Laboratories Ltd along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Dr Reddys Laboratories Ltd is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Dr Reddys Laboratories Ltd

Sign Up Free
Corporate Identity

Dr Reddys Laboratories Ltd (Stock Symbol: RDY) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Dr Reddys Laboratories Ltd's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Dr Reddys Laboratories Ltd...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Dr Reddys Laboratories Ltd...

Unlock Full Company Profile

Get complete details about Dr Reddys Laboratories Ltd

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Dr Reddys Laboratories Ltd...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Dr Reddys Laboratories Ltd...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Dr Reddys Laboratories Ltd...

Unlock Financial Analysis

Get complete financial metrics for Dr Reddys Laboratories Ltd

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Dr Reddys Laboratories Ltd's AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test
73.7% Rebalance periods with a positive net return
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Dr Reddys Laboratories Ltd strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Dr Reddys Laboratories Ltd competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Dr Reddys Laboratories Ltd (RDY) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Dr Reddys Laboratories Ltd stock analysis. Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.

Deep dive into Dr Reddys Laboratories Ltd's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Dr Reddys Laboratories Ltd stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Dr Reddys Laboratories Ltd:

Market Cap $10.34B
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Dr Reddys Laboratories Ltd converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Dr Reddys Laboratories Ltd:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Dr Reddys Laboratories Ltd's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Dr Reddys Laboratories Ltd:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Dr Reddys Laboratories Ltd's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Dr Reddys Laboratories Ltd:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Dr Reddys Laboratories Ltd uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Dr Reddys Laboratories Ltd:

Understanding Financial Statement Data

What these metrics mean: Key figures from Dr Reddys Laboratories Ltd's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Dr Reddys Laboratories Ltd:

Income Statement
Balance Sheet Highlights (USD millions)
Dividend & Shareholder Information
Shares Outstanding 835M

Latest Dr Reddys Laboratories Ltd Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Dr Reddys Laboratories Ltd (RDY) stock price and investment outlook.

📰 Loading...

Where RDY sits on the market map

Explore the map →

Dr Reddys Laboratories Ltd Industry Peers - Pharmaceutical Preparations

Companies classified under the same SEC industry code as Dr Reddys Laboratories Ltd (Pharmaceutical Preparations): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Company Ticker Symbol 90-Day AI Forecast (Alpha) Market Cap (USD M) P/E Ratio P/B Ratio
RDY ██% $10.34B x x
LLY ██% $1.08T 40.6x 110.2x
JNJ ██% $648.67B 30.8x 7.6x
ONC ██% $539.52B x 104.3x
ABBV ██% $468.43B 74.2x x
MRK ██% $365.34B 115.1x 8.7x
NVS ██% $272.31B x x
GSK ██% $214.26B x x
ABT ██% $180.26B 28.6x 3.5x
PFE ██% $160.62B 37.1x 1.9x
VRTX ██% $130.87B 29.7x 6.5x
BMY ██% $125.63B 13.5x 5.6x
REGN ██% $82.55B 19.1x 2.6x
SNY ██% $50.80B x x
TEVA ██% $45.46B 64.3x 5.9x
ALNY ██% $33.40B x 24.7x
RPRX ██% $33.15B 40.7x 4.9x
ATHE ██% $32.40B x x
TAK ██% $29.93B x x
ZLAB ██% $29.68B x 48.9x
ZTS ██% $29.59B 11.3x 9.4x
ROIV ██% $26.60B x 6.3x
INSM ██% $25.84B x 34.1x
UTHR ██% $20.99B 16.0x 3.3x
VTRS ██% $19.66B x x
JAZZ ██% $15.25B 16.2x 3.2x
ASND ██% $14.30B x x
SMMT ██% $13.12B x 20.8x
BBIO ██% $12.96B x x
CORT ██% $12.81B x 18.2x
HCM ██% $12.54B x 10.1x
BMRN ██% $11.88B x 1.9x
KNSA ██% $11.87B x 19.6x
MDGL ██% $11.85B x 22.6x
ELAN ██% $11.17B x 1.7x
AXSM ██% $10.27B x 123.3x
ARWR ██% $9.33B x 20.1x
CYTK ██% $9.13B x x
PTGX ██% $8.98B x 10.7x
PRAX ██% $7.88B x 5.9x
SYRE ██% $7.77B x 7.1x
GPCR ██% $7.71B x 5.7x
ABVX ██% $7.39B x x
IONS ██% $7.30B x 16.6x
ALKS ██% $6.84B x 3.8x
LEGN ██% $6.82B x x
RYTM ██% $6.76B x 65.7x
BLRX ██% $6.68B x x
BLTE ██% $6.67B x 8.7x
AMRX ██% $6.32B x x
LQDA ██% $6.04B x 31.0x
LGND ██% $5.95B 30.2x 6.2x
MIRM ██% $5.80B x x
AMRN ██% $5.64B x 12.7x
TVTX ██% $5.64B x 230.0x
COGT ██% $5.45B x 10.2x
PTCT ██% $5.20B x x
ERAS ██% $5.08B x 14.0x
DNTH ██% $5.07B x 4.3x
VKTX ██% $4.86B x 11.9x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Dr Reddys Laboratories Ltd Stock Forecast

How accurate are Dr Reddys Laboratories Ltd stock predictions?

A per-ticker accuracy statistic for RDY is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

What factors influence Dr Reddys Laboratories Ltd stock price forecasts?

Our analysis considers Dr Reddys Laboratories Ltd's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Dr Reddys Laboratories Ltd a good investment in 2026?

Based on our AI analysis, Dr Reddys Laboratories Ltd shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Dr Reddys Laboratories Ltd forecasts updated?

Dr Reddys Laboratories Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on September 24, 2026.

Want a simpler view of Dr Reddys Laboratories Ltd?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...